Patient tumors were divided into 2 groups based on median glycolysis scores determined by the expression levels of glycolysis-related genes (SLC2A1, HK2, GPI1, PFKL, PGK, ALDOA, PGAM, GAPDH, PFKM, ENO1, PKM, LDHA, and SLC16A3) in tumor cells. This evidence concerns the gene PFKL and neoplasm.